Russell Investments Group’s GoodRx Holdings GDRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-68,926
Closed -$135K 4436
2026
Q1
$135K Sell
68,926
-17,943
-21% -$42.1K ﹤0.01% 2986
2025
Q4
$235K Buy
86,869
+1,861
+2% +$6.11K ﹤0.01% 2782
2025
Q3
$360K Buy
85,008
+20,945
+33% +$92.1K ﹤0.01% 2611
2025
Q2
$319K Sell
64,063
-1,699
-3% -$7.38K ﹤0.01% 2500
2025
Q1
$290K Sell
65,762
-1,712
-3% -$8.04K ﹤0.01% 2483
2024
Q4
$314K Buy
+67,474
New +$371K ﹤0.01% 2414
2024
Q3
Sell
-6,230
Closed -$48.6K 3732
2024
Q2
$48.6K Sell
6,230
-1,131
-15% -$8.38K ﹤0.01% 2769
2024
Q1
$52.3K Hold
7,361
﹤0.01% 2663
2023
Q4
$49.3K Sell
7,361
-63,325
-90% -$357K ﹤0.01% 2640
2023
Q3
$398K Sell
70,686
-76,284
-52% -$509K ﹤0.01% 2304
2023
Q2
$811K Sell
146,970
-8,757
-6% -$47.1K ﹤0.01% 2032
2023
Q1
$973K Buy
155,727
+42,491
+38% +$237K ﹤0.01% 1984
2022
Q4
$528K Buy
113,236
+2,977
+3% +$14.7K ﹤0.01% 2267
2022
Q3
$513K Buy
+110,259
New +$695K ﹤0.01% 2233

Other funds holding GDRX

Russell Investments Group's GDRX Position: Q2 2026 in Review

Russell Investments Group sold out of GoodRx Holdings (GDRX) in Q2 2026, closing a stake of 68,926 shares — an estimated $135K sold.

Russell Investments Group first reported a position in GDRX in Q3 2022 and held it in 14 quarters. The position peaked at $973K in Q1 2023. 59 funds tracked by Wall St. Rank hold GDRX as of Q2 2026.

  • Russell Investments Group reported no remaining GoodRx Holdings position as of Q2 2026 after selling out during the quarter.
  • Russell Investments Group sold 68,926 GoodRx Holdings shares in Q2 2026, an estimated $135K.
  • Russell Investments Group first reported a position in GoodRx Holdings in Q3 2022 and held it in 14 quarters.
  • Russell Investments Group's GoodRx Holdings position peaked at $973K in Q1 2023.
  • 59 funds tracked by Wall St. Rank held GoodRx Holdings as of Q2 2026.

Based on Russell Investments Group's 13F filing for Q2 2026, filed 6 Aug 2026.